KIMS NSE filing

KIMS Hospitals Announces Q1 FY26 Results: Revenue ₹879 Cr, Up 26.8% YoY

The RealCase readMedium impact Positive

Why it matters

The results show significant growth in revenue, but a slight decrease in some profitability metrics, suggesting a moderate impact on the company's overall performance.

The market read

The announcement highlights strong revenue growth and positive operational performance, indicating a positive outlook for the company.

* KIMS Hospitals announced its Q1 FY26 results with a total revenue of ₹879 crore, reflecting a 26.8% year-on-year growth and a 9.6% quarter-on-quarter growth. * EBITDA stood at ₹200 crore, an 8.5% increase year-on-year but a 1.4% decrease quarter-on-quarter. * EBITDA margin was 22.7% compared to 26.6% in Q1 FY25 and 25.3% in Q4 FY25. * PAT reached ₹85 crore in Q1 FY26, against ₹95 crore and ₹106 crore in Q1 FY25 and Q4 FY25, respectively. * Consolidated EPS for Q1 FY26 was ₹1.96, a 9.2% decrease year-on-year. * Cash and Cash Equivalents stood at ₹70 crore as of Q1 FY26. * Consolidated Revenue from Operations was ₹872 crore, a 26.6% year-on-year and 9.4% quarter-on-quarter increase. * ARPOB grew by 11.8% year-on-year and 3.7% quarter-on-quarter. * ARPP grew by 9.8% year-on-year and 2.7% quarter-on-quarter. * Dr. B Bhaskar Rao, CMD, KIMS Hospitals, commented that the first quarter of FY26 started robustly and he is optimistic that the company is on track to meet its targets for FY26. He also mentioned that two units in Bangalore will be commencing in Q2.

Filing to action

What to do with a filing like this

Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.

View original filing